Dishman Pharma surges 13%

The company has been awarded manufacture of SIRTURO (bedaquiline) API.

Dishman Pharmaceuticals and Chemicals Ltd is currently trading at Rs. 299, up by 13% from its previous closing of Rs. 264.2 on the BSE.

The company has been awarded manufacture of SIRTURO (bedaquiline) API.

The scrip opened at Rs. 260.9 and has touched a high and low of Rs. 292.8 and Rs. 260 respectively. So far 3366992 shares were traded on the counter. The current market cap of the company is Rs. 2132.09 crore.

The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 274.45 on 22-Sep-2015 and a 52 week low of Rs. 102.55 on 17-Dec-2014. Last one week high and low of the scrip stood at Rs. 274.45 and Rs. 242.35 respectively.

The promoters holding in the company stood at 61.4 % while Institutions and Non-Institutions held 18.4 % and 20.2 % respectively.

The stock is currently trading below its 50 DMA.